A detailed history of Congress Asset Management CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Congress Asset Management CO holds 201,677 shares of LLY stock, worth $160 Million. This represents 1.25% of its overall portfolio holdings.

Number of Shares
201,677
Previous 202,109 0.21%
Holding current value
$160 Million
Previous $183 Million 2.36%
% of portfolio
1.25%
Previous 1.35%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$772.14 - $960.02 $333,564 - $414,728
-432 Reduced 0.21%
201,677 $179 Million
Q2 2024

Aug 02, 2024

SELL
$724.87 - $909.04 $17.3 Million - $21.6 Million
-23,808 Reduced 10.54%
202,109 $183 Million
Q1 2024

Apr 11, 2024

SELL
$592.2 - $792.28 $347,029 - $464,276
-586 Reduced 0.26%
225,917 $176 Million
Q4 2023

Mar 04, 2024

BUY
$525.19 - $619.13 $909,103 - $1.07 Million
1,731 Added 0.77%
226,503 $132 Million
Q3 2023

Nov 01, 2023

SELL
$434.7 - $599.3 $23.2 Million - $32 Million
-53,411 Reduced 19.2%
224,772 $121 Million
Q2 2023

Jul 27, 2023

SELL
$350.74 - $468.98 $718,315 - $960,471
-2,048 Reduced 0.73%
278,183 $130 Million
Q1 2023

Apr 21, 2023

SELL
$310.63 - $364.82 $1.47 Million - $1.73 Million
-4,743 Reduced 1.66%
280,231 $96.2 Million
Q4 2022

Jan 18, 2023

SELL
$321.55 - $374.67 $1.26 Million - $1.47 Million
-3,922 Reduced 1.36%
284,974 $0
Q3 2022

Nov 08, 2022

SELL
$296.48 - $337.87 $251,118 - $286,175
-847 Reduced 0.29%
288,896 $93.4 Million
Q2 2022

Aug 02, 2022

BUY
$278.73 - $327.27 $240,822 - $282,761
864 Added 0.3%
289,743 $93.9 Million
Q1 2022

Apr 20, 2022

BUY
$234.69 - $291.66 $67.8 Million - $84.3 Million
288,879 New
288,879 $82.7 Million
Q1 2019

May 08, 2019

SELL
$111.31 - $131.02 $193,679 - $227,974
-1,740 Closed
0 $0
Q4 2018

Jan 25, 2019

BUY
$105.9 - $118.64 $184,266 - $206,433
1,740 New
1,740 $201,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Congress Asset Management CO Portfolio

Follow Congress Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.